Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Yolanda S Jaimes"'
Autor:
Andreas-Claudius Hoffmann, Kathleen D. Danenberg, Jacek Pinski, Peter V. Danenberg, Mai Dang, Ronald Gonzales, Afsaneh Barzi, Luis E. Raez, Mary Grino, Hiroyuki Uetake, Yolanda S Jaimes, Rama Tyagi, Wilfried Eberhardt, Toshiyuki Ishiba, Heinz-Josef Lenz, Todd Sturdevant, Joshua L. Usher, Dirk Theegarten, Yahya Elshimali
Publikováno v:
Biochem Biophys Res Commun
Background Precision medicine and prediction of therapeutic response requires monitoring potential biomarkers before and after treatment. Liquid biopsies provide noninvasive prognostic markers such as circulating tumor DNA and RNA. Circulating tumor
Autor:
D. Sumarriva, Joshua L. Usher, Kathleen D. Danenberg, Peter V. Danenberg, Yolanda S Jaimes, Brian Hunis, Luis E. Raez, G. Domingo
Publikováno v:
Journal of Thoracic Oncology. 14:S1170
Autor:
Kathleen D. Danenberg, Aurelio B. Castrellon, Cheryl Habaue, Peter V. Danenberg, S. Rabizadeh, Luis E. Raez, Brian Hunis, Yolanda S Jaimes, Joshua L. Usher
Publikováno v:
Journal of Thoracic Oncology. 13:S423-S424
Autor:
Yolanda S Jaimes, Cheryl Habaue, Kathleen D. Danenberg, S. Rabizadeh, Brian Hunis, Joshua L. Usher, Peter V. Danenberg, Luis E. Raez
Publikováno v:
Journal of Thoracic Oncology. 13:S153-S154
Autor:
G. Domingo, Peter V. Danenberg, Yolanda S Jaimes, Luis E. Raez, Kathleen D. Danenberg, D. Sumarriva, S. Rabizadeh, Brian Hunis, Joshua L. Usher
Publikováno v:
Journal of Thoracic Oncology. 14:S386
Autor:
Hirofumi Ota, Yolanda S Jaimes, Peter V. Danenberg, Heinz-Josef Lenz, Kathleen D. Danenberg, Dai Manaka, Wataru Ichikawa, Masashi Fujii, Hisatsugu Ohori, Masato Matsuura, Mitsugu Kochi, Akihito Tsuji, Yu Sunakawa, Joshua L. Usher, Hironaga Satake, Masahiro Takeuchi, Takanori Watanabe, Manabu Shiozawa
Publikováno v:
Journal of Clinical Oncology. 37:TPS3621-TPS3621
TPS3621 Background: A randomized phase II trial, DEEPER (JACCRO CC-13) [NCT02515734], is on-going to evaluate FOLFOXIRI plus cetuximab (cet) vs. FOLFOXIRI plus bevacizumab (bev) in terms of depth of response as primary endpoint in 360 mCRC patients (
Autor:
Kathleen D. Danenberg, Aurelio Castrellon, Joshua L. Usher, Cheryl Habaue, Yolanda S Jaimes, Peter V. Danenberg, Michel Velez, Shahrooz Rabizadeh, Luis E. Raez, Brian Hunis
Publikováno v:
Journal of Clinical Oncology. 36:e15013-e15013
e15013Background: Analysis ofcell-free circulating tumor RNA (cfRNA) extracted from plasma of cancer patients (pts) provides a means of measuring dynamic changes in gene expression as well as level...
Autor:
M Velez, Yolanda S Jaimes, M Blaya, AB Castrellon, Cheryl Habaue, AC Bittencourt, Peter V. Danenberg, Luis E. Raez, Shahrooz Rabizadeh, K. Danenberg, Brian Hunis, A Milillo, Joshua L. Usher
Publikováno v:
Cancer Research. 78:P2-02
Background: In addition to traditional radiology tests, cell-free circulating tumor RNA (cfRNA) extracted from plasma of cancer patients (pts) provides a means of evaluating tumor response, but based on molecular changes in the tumor. Measuring dynam
Autor:
Takanori Watanabe, Kathleen D. Danenberg, Masato Nakamura, Heinz-Josef Lenz, Masahiro Takeuchi, Chihiro Tanaka, Takashi Sekikawa, Hiroshi Nakayama, Yolanda S Jaimes, Masahiro Gotoh, Joshua L. Usher, Yu Sunakawa, Hironaga Satake, Nobuhiro Sugano, Akinori Takagane, Kiyoshi Ishigure, Masashi Fujii, Yuji Miyamoto, Wataru Ichikawa
Publikováno v:
Journal of Clinical Oncology. 36:635-635
635 Background: We have reported that modified (m)-FOLFOXIRI plus bev was feasible and had a good objective response rate (ORR) for Japanese patients (pts) in a phase II trial of the JACCRO CC-11 (ESMO 2017 #543P). In addition, a pre-planned research
Autor:
Kathleen D. Danenberg, Aurelio Castrellon, Yolanda S Jaimes, Brian Hunis, Michel Velez, Peter V. Danenberg, Luis E. Raez, Joshua L. Usher, Cheryl Habaue
Publikováno v:
Journal of Clinical Oncology. 35:11550-11550
11550 Background: There is an unmet need to evaluate tumor response by other means than radiology tests. Changes in gene expression, allele-fractions of mutations, PDL-1 expression and levels of cell free DNA [DNA] or RNA [RNA] in plasma might be use